OpenURL Connection Search

Select item for more details and to access through your institution.

Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone.
Published in:
Clinical Pharmacology & Therapeutics, 1998, v. 64, n. 1, p. 106, doi. 10.1016/S0009-9236(98)90028-5
By:
- Trocóniz, Iñaki F.;
- Naukkarinen, Tarja H.;
- Ruottinen, Hanna M.;
- Rinne, Urpo K.;
- Gordin, Ariel;
- Karlsson, Mats O.
Publication type:
Article
[18F]FDOPA and [18F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.
Published in:
Synapse, 2001, v. 40, n. 3, p. 193, doi. 10.1002/syn.1042
By:
- O. Rinne, Juha;
- Nurmi, Elina;
- Ruottinen, Hanna M.;
- Bergman, Jörgen;
- Eskola, Olli;
- Solin, Olof
Publication type:
Article
Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.
Published in:
Synapse, 2001, v. 40, n. 1, p. 19, doi. 10.1002/1098-2396(200104)40:1<19::AID-SYN1022>3.0.CO;2-7
By:
- Ruottinen, Hanna M.;
- Niinivirta, Mikko;
- Bergman, Jörgen;
- Oikonen, Vesa;
- Solin, Olof;
- Eskola, Olli;
- Eronen, Esa;
- Sonninen, Pirkko;
- Rinne, Urpo K.
Publication type:
Article
Striatal 6-[18F]fluorodopa accumulation after combined inhibition of peripheral catechol- O-methyltransferase and monoamine oxidase type B: Differing response in relation to presynaptic dopaminergic dysfunction.
Published in:
Synapse, 1997, v. 27, n. 4, p. 336, doi. 10.1002/(SICI)1098-2396(199712)27:4<336::AID-SYN7>3.0.CO;2-D
By:
- Ruottinen, Hanna M.;
- Rinne, Juha O.;
- Oikonen, Vesa J.;
- Bergman, Jörgen R.;
- Haaparanta, Merja T.;
- Solin, Olof H.;
- Ruotsalainen, Ulla H.;
- Rinne, Urpo K.
Publication type:
Article
Rate of progression in Parkinson's disease: A 6-[18F]fluoro-L-dopa PET study.
Published in:
Movement Disorders, 2001, v. 16, n. 4, p. 608, doi. 10.1002/mds.1139
By:
- Nurmi, Elina;
- Ruottinen, Hanna M.;
- Bergman, Jörgen;
- Haaparanta, Merja;
- Solin, Olof;
- Sonninen, Pirkko;
- Rinne, Juha O.
Publication type:
Article
Upregulation of Putaminal Dopamine D2 Receptors in Early Parkinson's Disease: A Comparative PET Study with [11C]Raclopride and [11C]N-Methylspiperone.
Published in:
Journal of Nuclear Medicine, 2000, v. 41, n. 1, p. 65
By:
- Kaasinen, Valtteri;
- Ruottinen, Hanna M.;
- Någren, Kjell;
- Lehikoinen, Pertti;
- Oikonen, Vesa;
- Rinne, Juha .
Publication type:
Article
PET Studies on Brain Monoamine Transporters with Carbon-11-β-CIT in Parkinson's Disease.
Published in:
Journal of Nuclear Medicine, 1995, v. 36, n. 7, p. 1263
By:
- Laihinen, Arto O.;
- Rinne, Juha O.;
- Någren, Kjell Å.;
- Lehikoinen, Pertti K.;
- Oikonen, Vesa J.;
- Ruotsalainen, Ulla H.;
- Ruottinen, Hanna M.;
- Rinne, Urpo K.
Publication type:
Article
PET Studies on Dopamine D1 Receptors in the Human Brain with Carbon-11-SCH 39166 and Carbon-11-NNC 756.
Published in:
Journal of Nuclear Medicine, 1994, v. 35, n. 12, p. 1916
By:
- Laihinen, Arto O.;
- Rinne, Juha O.;
- Ruottinen, Hanna M.;
- Någren, Kjell Å.;
- Lehikoinen, Pertti K.;
- Oikonen, Vesa J.;
- Ruotsalainen, Ulla H.;
- Rinne, Urpo K.
Publication type:
Article

Found: 8

Population pharmacodynamic modeling of levodopa in patients with Parkinson's disease receiving entacapone.

[<sup>18</sup>F]FDOPA and [<sup>18</sup>F]CFT are both sensitive PET markers to detect presynaptic dopaminergic hypofunction in early Parkinson's disease.

Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging.

Striatal 6-[<sup>18</sup>F]fluorodopa accumulation after combined inhibition of peripheral catechol- O-methyltransferase and monoamine oxidase type B: Differing response in relation to presynaptic dopaminergic dysfunction.

Rate of progression in Parkinson's disease: A 6-[<sup>18</sup>F]fluoro-L-dopa PET study.

Upregulation of Putaminal Dopamine D2 Receptors in Early Parkinson's Disease: A Comparative PET Study with [<sup>11</sup>C]Raclopride and [<sup>11</sup>C]N-Methylspiperone.

PET Studies on Brain Monoamine Transporters with Carbon-11-β-CIT in Parkinson's Disease.

PET Studies on Dopamine D1 Receptors in the Human Brain with Carbon-11-SCH 39166 and Carbon-11-NNC 756.